Ami Organics inks MoU with a global manufacturer of electrolytes
Ami Organics will also sign an MoU with Government of Gujarat for investment amounting up to Rs 300 crores for set up of dedicated manufacturing facility for electrolytes business
Ami Organics will also sign an MoU with Government of Gujarat for investment amounting up to Rs 300 crores for set up of dedicated manufacturing facility for electrolytes business
Development services for gene and cell therapies is planned to begin first in 2025
The launch of R3SET Detox Candies positions the brand at the forefront of the wellness journey
Additionally, Rs. 12.85 crores shall be infused into the P H Diagnostic by way of either Equity or Loan to pay the existing debt
This development is a strategic part of the company's commitment to bolstering its position in the advanced pharmaceutical intermediates segment
his marks the 12th formulation facility under Akums, and the second in Baddi, a strategic move with an aim to enhance Akums’ manufacturing capabilities.
Dr. Reddy's will make a US$ 7.5 million upfront payment to Coya
Venus Remedies is supplying the drug to many countries like Colombia, Thailand, Tanzania, Morocco, Myanmar, Indonesia, Saudi Arabia, Malaysia, Zimbabwe, Sri Lanka, Pakistan, Kenya, and Botswana
The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output
Currently, Venkat is Lead – Market Access, India at Pfizer
Subscribe To Our Newsletter & Stay Updated